How Can Pharmacists Best Support Patients With Chronic Lymphocytic Leukaemia? The PJ Pod podcast

Artwork

Science PJ Pod Pharmaceutical Journal

Innehåll tillhandahållet av The PJ Pod and Pharmaceutical Journal. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av The PJ Pod and Pharmaceutical Journal eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

The PJ Pod « »
How can pharmacists best support patients with chronic lymphocytic leukaemia?

2M ago 30:48

Dela

MP3•Episod hem

Innehåll tillhandahållet av The PJ Pod and Pharmaceutical Journal. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av The PJ Pod and Pharmaceutical Journal eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

Over the last decade, the development of targeted therapies has significantly changed the way that chronic lymphocytic leukaemia (CLL) is treated. Survival and life expectancy has improved, and this patient cohort is living and receiving treatment for longer than ever before. These changes have meant that the involvement of pharmacists across all sectors in the treatment of CLL patients has also evolved significantly. In this episode of The PJ Pod, Caitlin Killen, assistant clinical editor, speaks to a patient who has been living with CLL for 17 years, as well as with two pharmacists involved in the care of CLL patients, to understand how pharmacists can best support patients with CLL. Many thanks to expert patient Anthea Holland; Catherine Parbutt, consultant pharmacist for cancer services, The Leeds Teaching Hospitals NHS Trust; and Tejal Gorasia, principal cancer pharmacist, Milton Keynes University Hospital NHS Foundation Trust, for their expertise. This episode was produced by Geoff Marsh.

… continue reading

48 episoder

#Science #PJ Pod #Pharmaceutical Journal

Artwork

How can pharmacists best support patients with chronic lymphocytic leukaemia?

published 2M ago

Dela

MP3•Episod hem

Innehåll tillhandahållet av The PJ Pod and Pharmaceutical Journal. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av The PJ Pod and Pharmaceutical Journal eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

Over the last decade, the development of targeted therapies has significantly changed the way that chronic lymphocytic leukaemia (CLL) is treated. Survival and life expectancy has improved, and this patient cohort is living and receiving treatment for longer than ever before. These changes have meant that the involvement of pharmacists across all sectors in the treatment of CLL patients has also evolved significantly. In this episode of The PJ Pod, Caitlin Killen, assistant clinical editor, speaks to a patient who has been living with CLL for 17 years, as well as with two pharmacists involved in the care of CLL patients, to understand how pharmacists can best support patients with CLL. Many thanks to expert patient Anthea Holland; Catherine Parbutt, consultant pharmacist for cancer services, The Leeds Teaching Hospitals NHS Trust; and Tejal Gorasia, principal cancer pharmacist, Milton Keynes University Hospital NHS Foundation Trust, for their expertise. This episode was produced by Geoff Marsh.

… continue reading

48 episoder

#Science #PJ Pod #Pharmaceutical Journal

Alla avsnitt

×

Välkommen till Player FM

Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.

Lyssna på 500+ ämnen